Singapore – Clementia Pharmaceuticals, a clinical-stage biopharmaceutical company innovating new treatments for pe...
X4 Pharmaceuticals, a clinical-stage biotechnology company developing novel CXCR4 allosteric antagonist drug candidates ...
Accenture has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process ...
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for a next-generation version of its leadi...
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-c...
Qiagen has announced a partnership with multiple organizations to support creating a global genomics campus in Mancheste...
Researchers have found a wearable patch that acts like a sensor can effectively improve the diagnosis rate for heart rhy...
Thermo Fisher Scientific has signed an agreement with reagent intelligence platform BenchSci to use its trademarked mach...
Duke University has announced a new collaboration with Microsoft in several areas including research and cognitive servi...
Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, announced that it has entered into a...
After 15 years at Gilead, Adrian Ray, Senior Director of Clinical Research, Gilead Sciences has moved over to Nimbus The...
Singapore – G1 Therapeutics, a clinical-stage oncology company, announced appointments for two newly created ...
Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seve...
Singapore – Amphastar Pharmaceuticals announced business expansion plans for its subsidiary, Amphastar Nanjin...
Singapore – CUTERA, a leading provider of laser, light and other energy-based aesthetic systems for practitio...
At the Intelligent Medicines' Future Decoded event co-hosted by Microsoft, Indegene and PAREXEL, life sciences l...
President Yoweri Museveni has requested GE Healthcare to move with speed and conclude discussions with the health and fi...
Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an...
